Viewing nowHanoll Rosuvastatin Calcium Tablet 10 Milligrams
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

MFDS item code 201400970 · Approved 2014.02.28
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of the progression of atherosclerosis
This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia who are not adequately controlled with diet and exercise alone. It is also used in patients with homozygous familial hypercholesterolemia in combination with diet or other lipid-lowering therapies to lower total cholesterol and LDL-cholesterol levels, thereby delaying the progression of atherosclerosis. It may also be prescribed as an adjunct therapy for children aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet certain criteria. It is also beneficial in the treatment of primary dysbetalipoproteinemia. Additionally, in certain high-risk patients, it effectively reduces the risk of stroke, myocardial infarction, and arterial revascularization, thereby reducing cardiovascular disease risk. Thus, this medication is used in the treatment and prevention of hypercholesterolemia and associated cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the maintenance dose may be adjusted if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Older adults: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to its components, have severely impaired liver function, have muscle diseases, are on certain immunosuppressants, have severe renal dysfunction, are pregnant or breastfeeding, and for fertile women who are not using appropriate contraception. Additionally, high doses are prohibited in patients at high risk of muscle-related side effects. Risk factors include moderate renal dysfunction, hypothyroidism, a family history of muscle disorders, alcohol abuse, and concomitant medications. This medication contains lactose, so it should not be used by patients with lactose intolerance or related genetic disorders. When using this medication, it is important to periodically monitor liver function tests and muscle status. Patients who consume large amounts of alcohol or have a history of liver disease should exercise extra caution, and if symptoms such as myalgia, muscle weakness, or cramps occur, they should immediately inform their medical provider. This medication may increase blood sugar levels in some patients, so patients at risk of diabetes should pay attention to their blood sugar management. When taking this medication with other drugs, the possibility of interactions should be considered. When used with certain medications, the blood concentration of this medication may increase, raising the risk of muscle side effects; thus, it should be discussed with a healthcare provider. Pregnant or breastfeeding women should not take this medication, and women planning to become pregnant should use appropriate contraceptive methods. In case of overdose, there are no specific antidotes, so management should be based on symptoms along with liver function and muscle enzyme tests. Care should be taken as this medication may cause dizziness when driving or operating machinery. Finally, this medication may rarely cause serious skin reactions, liver damage, renal problems, and other side effects in some patients, so any adverse symptoms should be reported to a healthcare provider immediately.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, severe myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia gravis, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug eruption resembling lichen planus, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. The proper storage temperature is between 1 to 30 degrees Celsius at room temperature, and it should be kept away from excessively hot or cold places.
Pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.